Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics

Biotechnology Value Fund L.P. reduced its stake in MoonLake Immunotherapeutics by 2,000,000 shares, representing a 9.19% decrease, at $55.28 per share. Despite this reduction, the firm still holds 31.